QLT, Kinetek signal transduction deal

QLT (TSE:QLT; QLTI) and Kinetek (Vancouver, B.C.) will develop signal transduction inhibitors to treat ophthalmic, immune system and kidney diseases. QLT invested C$11 million (US$7.2 million) in Kine...